Nanomaterials‐Induced Pyroptosis: Advancing Novel Therapeutic Pathways in Nanomedicine
Small Methods · 2025-07 · 9 (7)
DOI: 10.1002/smtd.202401290 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 24.01.2025. Verfasst von Siqi Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience …. Hauptthemen laut MEDLINE: Pyroptosis, Nanomedicine, Nanostructures. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Basic Science Center Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Pyroptosis, a form of programmed cell death characterized by cell lysis and inflammation, has significant implications for disease treatment. Nanomaterials (NMs), with their unique physicochemical properties, can precisely modulate pyroptosis, offering novel and intelligent therapeutic strategies for cancer, infectious diseases, and chronic inflammatory conditions with targeted activation and reduced systemic toxicity. This review explores the mechanisms by which NMs regulate pyroptosis, comparing molecular and NM inducers, and examines the role of intrinsic properties such as size, shape, surface charge, and chemical composition in these processes. It also discusses the balance between the beneficial and adverse effects of NM‐induced pyroptosis, highlighting targeted delivery systems, surface modifications, and controlled activation as strategies to enhance therapeutic efficacy and intelligence while minimizing toxicity. Notably, mRNA‐based nanomedicine can be precisely and intelligently designed to activate pyroptosis, achieving desired therapeutic outcomes tailored to the evolving microenvironment of diseases. By understanding these interactions, the therapeutic potential of NMs can be harnessed to develop innovative treatments and manage pyroptosis‐associated diseases safely, effectively, and intelligently. This review also highlights their transformative potential in clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), Beijing, 100190, China.
- Intern student at NCNST and currently studying at the University of Rochester, Rochester, NY, 14627, USA.
ORCID-Profile: Huan Meng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Basic Science Center Project of the National Natural Science Foundation of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- CAS Project for Young Scientists in Basic Research
Zitieren
APA
Yu, S., Zhang, Y., Zhou, Z., Li, J., & Meng, H. (2025). Nanomaterials‐Induced Pyroptosis: Advancing Novel Therapeutic Pathways in Nanomedicine. Small Methods, 9(7). https://doi.org/10.1002/smtd.202401290
Vancouver
Yu S, Zhang Y, Zhou Z, Li J, Meng H. Nanomaterials‐Induced Pyroptosis: Advancing Novel Therapeutic Pathways in Nanomedicine. Small Methods. 2025;9(7). doi:10.1002/smtd.202401290
BibTeX
@article{Yu2025,
author = {Yu, Siqi and Zhang, Yumo and Zhou, Zhuoran and Li, Jiulong and Meng, Huan},
title = {Nanomaterials‐Induced Pyroptosis: Advancing Novel Therapeutic Pathways in Nanomedicine},
journal = {Small Methods},
year = {2025},
volume = {9},
number = {7},
doi = {10.1002/smtd.202401290}
}
EUVIMED